Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cowan

Showing results (911-920 of 1,002) with videos related to

Pageof 101
Sort By:
Blood|March 10, 2001
Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor ProgramA H Filipovich, J V Stone, S C Tomany, et al.
Frontiers in Immunology|June 6, 2025
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity PlatformJoanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, et al.
Blood|November 1, 2011
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivoMike Recher, Lucinda J Berglund, Danielle T Avery, et al.
ACS Nano|June 24, 2026
Template-Confined Synthesis of 1 nm High-Entropy-Alloy Nanoparticle Library for ElectrocatalysisChun-Wei Chang, Yueh-Chun Hsiao, Jui-Tai Lin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 17, 2025
The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: Specifications for classification of variants in ADA, DCLRE1C, IL2RG, IL7R, JAK3, RAG1, and RAG2Vanessa C Jacovas, Michelle Zelnick, Shannon McNulty, et al.
The New England Journal of Medicine|December 22, 2022
Lentiviral Gene Therapy for Artemis-Deficient SCIDMorton J Cowan, Jason Yu, Janelle Facchino, et al.
Combinatorial Chemistry & High Throughput Screening|August 17, 2005
Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mappingMillard H Lambert, R Kevin Blackburn, Theresa D Seaton, et al.
Blood|April 8, 2025
A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-upSherilyn A Tuazon, Andrew J Portuguese, Margot J Pont, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: Specifications for classification of variants in <i>ADA</i> , <i>DCLRE1C</i> , <i>IL2RG</i> , <i>IL7R</i> , <i>JAK3</i> , <i>RAG1</i> , and <i>RAG2</i>Vanessa C Jacovas, Michelle Zelnick, Shannon McNulty, et al.
Journal of Clinical Immunology|July 3, 2013
The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901Christopher C Dvorak, Morton J Cowan, Brent R Logan, et al.
Pageof 101

Showing results (911-920 of 1,002) with videos related to

Sort By:
Pageof 101
Blood|March 10, 2001
Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor ProgramA H Filipovich, J V Stone, S C Tomany, et al.
Frontiers in Immunology|June 6, 2025
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity PlatformJoanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, et al.
Blood|November 1, 2011
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivoMike Recher, Lucinda J Berglund, Danielle T Avery, et al.
ACS Nano|June 24, 2026
Template-Confined Synthesis of 1 nm High-Entropy-Alloy Nanoparticle Library for ElectrocatalysisChun-Wei Chang, Yueh-Chun Hsiao, Jui-Tai Lin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 17, 2025
The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: Specifications for classification of variants in ADA, DCLRE1C, IL2RG, IL7R, JAK3, RAG1, and RAG2Vanessa C Jacovas, Michelle Zelnick, Shannon McNulty, et al.
The New England Journal of Medicine|December 22, 2022
Lentiviral Gene Therapy for Artemis-Deficient SCIDMorton J Cowan, Jason Yu, Janelle Facchino, et al.
Combinatorial Chemistry & High Throughput Screening|August 17, 2005
Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mappingMillard H Lambert, R Kevin Blackburn, Theresa D Seaton, et al.
Blood|April 8, 2025
A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-upSherilyn A Tuazon, Andrew J Portuguese, Margot J Pont, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: Specifications for classification of variants in <i>ADA</i> , <i>DCLRE1C</i> , <i>IL2RG</i> , <i>IL7R</i> , <i>JAK3</i> , <i>RAG1</i> , and <i>RAG2</i>Vanessa C Jacovas, Michelle Zelnick, Shannon McNulty, et al.
Journal of Clinical Immunology|July 3, 2013
The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901Christopher C Dvorak, Morton J Cowan, Brent R Logan, et al.
Pageof 101